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Abstract
Rapid growth in the young pig requires an episodic pattern of growth hormone (GH) secretion. We
developed different neurosurgical techniques to elucidate sites within the hypothalamus, a lower part of the
brain, that regulate GH release in this species. A focus of this research is administration of small brain peptide
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Summary and Implications
Rapid growth in the young pig requires an episodic
pattern of growth hormone (GH) secretion. We developed
different neurosurgical techniques to elucidate sites within
the hypothalamus, a lower part of the brain, that regulate
GH release in this species. A focus of this research is
administration of small brain peptide and nonpeptide
hormones that acutely affect GH release to define
mechanisms of action and their efficacy in augmenting
growth.
Introduction
The hypothalamus in the lower part of the brain
regulates both basal and episodic secretion of growth
hormone (GH), as well as the secretion of other anterior
pituitary hormones such as prolactin, adrenocortropin,
follicle stimulating hormone, luteinizing hormone, and
thyroid stimulating hormone. For each of these anterior
pituitary hormones, small brain peptides (from 189 to 5,108
molecular weight) stimulate or inhibit the secretion of larger
proteins (from 4541 to _32,000 molecular weight).
GH-releasing hormone (GHRH) or factor (GRF)
containing 44 amino acids stimulates GH release whereas
GH-release-inhibiting factor, somatostatin (SRIF), from the
hypothalamus inhibits GH release by the pituitary gland.
We have developed neurosurgical techniques of
hypophysectomy, hypophyseal stalk transection,
hypothalamic deafferentation, and intracerebroventricular
cannulation to determine central nervous system regulation
of GH secretion in the young, growing pig. With these
surgical interventions, selective brain peptide or pituitary
hormone replacement is administered intravenously or
intracerebroventricularly to determine acute regulation of GH
release by radioimmunoassay of GH concentration in
sequential blood samples. With the discovery of GH-
releasing peptides in 1977 by Bowers and colleagues,
consisting of derivatives of the pentapeptide Met-enkephalin,
a series of synthetic hexapeptide and nonpeptidyl GH
secretagogues are of interest for determining their
mechanisms of action in the central nervous system (4).
This report summarizes aspects of our studies on central
mechanisms regulating GH secretion in the pig.
Materials and Methods
Animals. Yorkshire gilts and castrate males (20Ð45 kg body
weight) were used in these studies. Animals were maintained
in individual pens for the duration of the study, and a ration
containing 14% crude protein was available ad libitum.
Light was provided for 12 hours per day. The animals were
fitted with a jugular vein cannula for repeat blood sampling.
Surgical procedures. For all surgical procedures the animals
were intravenously injected with sodium pentothal or
thiamylal sodium and intubated with an endotracheal catheter
for maintenance of anesthesia on a closed circuit system of
halothane (1Ð5%) and oxygen (200Ð500 cc/min). Before
surgery the animals were given cortisone acetate (25 mg,
intramuscularly) and intravenously infused with 20%
mannitol solution during surgery. Postoperatively the
animals were infused with 5% glucose solution (100Ð250
ml) and monitored for body temperature, respiration, and
return of normal feed consumption.
a) Hypophysectomy (HYPOX). A supraorbital surgical
approach was used to lift the left cerebral hemisphere for
exposure to cut the hypophyseal stalk and remove the
pituitary gland (1,2). The sella turcica was swabbed with
Bouin's fluid to destroy any remaining pituitary cells, and
then the recess was filled with thrombin-soaked gel foam.
Sham-operated controls (SOC) received the same surgical
intervention without removal of the pituitary gland.
b) Hypophyseal stalk transection (HST). A similar
surgical approach was used to expose the pituitary gland and
sever the hypophyseal stalk, and to insert a nylon barrier to
prevent vascular regeneration of the pituitary gland to the
stalk at the base of the brain (3,6,8). SOC animals received
the same surgical intervention without disturbing the
hypophyseal stalk.
c) Hypothalamic deafferentation. Animals were placed in
ventral recumbency with the head immobilized in a specially
designed stereotaxic apparatus by the procedures we described
previously (9,10). The calvarium was exposed with a
modified Halasz knife, especially designed for growing pigs.
The knife formed an arc of 7-mm height and 3.75-mm
radius. For anterior hypothalamic deafferentation (AHD) the
knife was inserted between the cerebral hemispheres with the
arc in an anterior position, lowered to the floor of the
calvarium, elevated 2.5 mm, and rotated 180_ twice before
returning to midline and removed (Figure 1). For posterior
hypothalamic deafferentation (PHD) the knife was inserted
with the arc in a posterior position and rotated 180_ twice
before removal. For complete hypothalamic deafferentation
(CHD) the knife was inserted as previously described and
rotated 360_ twice before removal. Sham-operated controls
received the same surgical procedures except the knife was
not rotated, and therefore no cut was performed in the
hypothalamus.
d) Intracerebroventricular cannulation (icv). We
developed stereotaxic coordinates for inserting 18-cm gauge
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stainless steel cannula in the left lateral-cerebral ventricle
according to predetermined coordinates (anterior-posterior, +
14 mm; lateral, 6 mm to the bregma; horizontal, 18 mm to
the dura mater (5,7). Stainless steel screws and cranioplastic
cement secured the cannula. Backflow of cerebrospinal fluid
indicated the cannula was icv.
Experimental design and statistical analysis. For each
experiment, appropriate numbers of experimental and SOC
were included to determine statistically valid inferences.
Experimental units were the individual animals assigned to
treatment at random. Temporal endocrine results were
analyzed by split-plot analysis of variance. The main plot
effect was treatment tested against animal within treatment
as the whole-plot error. Student's t-test was used for
comparison between treatment groups.
Results
In immature, hypophysectomized control pigs given
saline treatment, growth was markedly limited compared
with SOC. Daily injection of porcine GH or rat GH in
hypophysectomized for 40 days increased daily gain to 0.284
and 0.257 kg/d compared with 0.245 and 0.745 kg/d in
HYPOX controls and SOC. Results indicated that low daily
levels of GH induced significant increases in body weight
and protein anabolism in immature, hypophysectomized
pigs but that treatment responses were transitory.
Hypophyseal stalk transection abolished normal
episodic release of GH and depressed growth rates compared
with SOC immature pigs (Table 1). However, HST pigs
continue daily gains significantly greater than seen in saline-
treated hypophysectomized animals. The regulation of
prolactin (PRL) secretion is tonically inhibited in the intact,
growing animal. After HST, PRL blood concentrations
significantly increased compared with those in SOC pigs
throughout a 9-day postoperative period even though
pituitary concentration and content in HST pigs was greatly
reduced (Table 1). Thus, PRL is synthesized and
immediately released to maintain consistently greater
circulating concentrations of PRL in HST compared with
SOC pigs.
Hypothalamic deafferentation reduced mean blood serum
concentrations of GH after AHD, CHD, and PHD when
compared with SOC gilts (Figure 2). Furthermore, episodic
GH release evident in SOC animals was obliterated after
hypothalamic deafferentation. Prolactin concentrations in
peripheral serum of hypothalamic deafferentated gilts
remained similar (P>0.05) to those in SOC animals. These
results indicate that anterior and posterior hypothalamic
neural pathways play a minor role in control of PRL
secretion in the pig in as much as PRL levels remained
unchanged after hypothalamic deafferentation. These findings
may be interpreted to suggest that the hypothalamus by
itself seems able to maintain tonic inhibition of PRL
release. In contrast, the maintenance of episodic GH
secretion depends upon its neural connections traversing the
anterior and posterior aspects of the hypothalamus in the
pig.
The HST and stalk-intact pigs provide useful models to
determine the effects of analogs of GH-releasing factors
(GHRF), somatostatin (SRIF), arginine, and other brain
peptides on regulation of GH release by the pituitary gland.
HST and SOC gilts were challenged with intravenous
injections of human pancreatic GHRF(1-40)OH, thyrotropin
releasing hormone, and analogs of rat hypothalamic GHRF.
HST animals remained acutely responsive to GHRF by
releasing 2-fold greater quantities of GH than seen in SOC
controls (Figure 3). This occurred in spite of a 38%
reduction in pituitary gland weight and a 32 and 55%
decrease in GH concentration and total content, respectively
(Table 1). During SRIF infusion, GH remained at similar
basal concentrations in HST and control gilts, but increased
immediately after stopping SRIF infusion only in the
controls. Releasable pituitary GH appears to accumulate
during SRIF. GHRF given during SRIF infusion caused a 2-
fold greater release of GH than seen in animals receiving
only GHRF. Arginine increased GH release in controls, but
not in HST gilts, which suggests that it acts through the
central nervous system. Thyrotropin releasing hormone
acutely elevated circulating PRL in HST gilts, suggesting
that it acts directly in the pituitary gland. These results
indicate that the isolated pituitary after HST remains acutely
responsive to hypothalamic releasing and inhibiting factors
for both GH and PRL release in the pig.
To investigate the effect of hypophyseal stalk
transection on GH secretagogue activity of the non-peptidyl
GH secretagogue, L-692,585, in the conscious pig, castrate
male Yorkshire pigs were randomly assigned to either HST
or SOC (6). Treatments administered intravenously were L-
692,585 (100 _g/kg body weight), human GH-releasing
factor (1-29)NH2 (GHRH; 20 _g/kg body weight), or L-
692,585 + GHRH at the same dosages in days -7 to -3
before brain surgery and days +3 and +8 after surgery, and
blood was collected for radioimmunoassay of GH. The
magnitude of GH release was greatest in L-692,585 injected-
pigs (Figure 4). When L-692,585 and GHRH were
intravenously injected together the GH response was more
than additive. The pigs then were separated into two
experimental groups and subjected to HST or SOC surgery,
and again treated with the same dosages of the secretagogues.
The magnitude of GH secretion was diminished in stalk-
transected pigs treated with L-692,585, but when GHRH
was replaced exogenously, L-692,585 provided GH release of
a magnitude indistinguishable from that of controls (Figure
4), suggesting that GHRH is released by the hypothalamus
in response to L-692,585. When the same HST pigs were
given luteinizing hormone-releasing hormone and
corticotropin-releasing hormone, normal LH and ACTH
responses were measured, indicating that surgical
intervention had not compromised the functional integrity of
the pituitary gland.
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To investigate the acute dose-dependent effect of the GH
secretagogue on GH release, L-692,585 was administered icv
in castrate Yorkshire male pigs (5). Peak GH plasma levels
(ng/ml) following L-692,585 icv treatment at 3 (23_9; _
standard error), 10 (25_10), or 30 _g/kg (38_6) occurred at
10 minutes and returned to baseline (<4 ng/ml) by 60
minutes, and were significantly (P<0.01) greater than
following saline treatment (1.5_ 1). These results indicate
that L-692,585 when administered icv caused a GH response
of equal magnitude to that following intravenous
administration.
Discussion
Different cranial surgical interventions revealed aspects
of central nervous system regulation of growth hormone
secretion in the young, growing pig. Complete surgical
removal of the pituitary gland (hypophysectomy) arrested
growth, whereas daily GH replacement in such animals
significantly increased growth but at a rate less than seen in
SOC animals. In the intact young, growing pig, GH
secretion is episodic, with 3 to 6 peaks of 6 to 12 ng/ml of
plasma during a 6-hour period. Endogenous secretion of
hypothalamic GHRH causes episodic patterns of GH release
because after hypophyseal stalk transection they are
abolished. Regardless, growth continues in such HST pigs
but at a slower rate than seen in SOC. When the GHRH is
intravenously injected into HST pigs, they respond with
abrupt peak GH release indicating continued GH synthesis
by the isolated pituitary gland in spite of reduced gland size
(i.e., 38% less than SOC animals). The GH response to
GHRH injection in HST pigs is less than sustained in SOC
animals. The intravenous injection of the nonpeptidyl GH
secretagogue, L-692,585, elicited an abrupt GH release in
HST pigs but a peak response less than seen in SOC
controls. When the GH secretagogue, L-692,585, was
coadministered with GHRH, the GH response was the same
magnitude as seen in SOC animals. These results may be
interpreted to suggest that the novel GH secretagogue may
act through GHRH to augment GH release, interfere with
SRIF secretion, or act independently at the level of the
hypothalamus and pituitary gland. In the rat, intravenous or
icv injection of L-692,585 activates c-fos protein expression
selectively in the arcuate nucleus; activation is association
with neurosecretory neurons. In contrast, GHRH
administered by itself is ineffective in eliciting this
immunoactivity. The selective localization of c-fos
immunoactivity in a specific region of the arcuate nucleus
suggests that these GH-secretagogues directly or indirectly
target GHRH-containing neurons. The dose-dependent effects
of icv injected L-692,585 on GH release in the immature pig
reinforces the idea of central activation of neurosecretory
neurons in the hypothalamus.
                  Conclusions
The central nervous system regulation of an episodic
pattern of growth hormone secretion requires endogenous
brain peptide hormones that stimulate and inhibit GH release
in the young, growing pig. We have developed neurosurgical
techniques to reveal sites of action within the basal region of
the brain (hypothalamus) that regulate GH release by the
pituitary gland in this species. In addition, small peptide and
nonpeptide hormones have been administered to reveal in the
hypothalamus, neuronal secretory cells that regulate GH
secretion. An understanding of hormonal mechanisms within
the brain that control GH secretion will lead to effective
ways to augment growth in the pig.
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Figure 1. A camera lucida drawing of the sagittal view of the
porcine thalamus and hypothalamus with a depiction of the
areas isolated by the knife. Interrupted lines define the arc for
position of anterior and posterior knife cuts. The
mammillary bodies (MB), mammillothalamic tract (MT),
fornix (F), dorsomedial nucleus (DM), ventromedial nucleus
(VM), arcuate nucleus (AN), posterior nucleus (P), optic
chiasm (OC), massa intermedia (MI), and pituitary stalk
(PS) are indicated. 2.7X
Figure 2. GH concentrations in peripheral serum in
ovariectomized prepuberal gilts during anesthesia and early
recovery (Day 0) and 24 and 48 hours after hypothalamic
deafferentation (Days 1 and 2, respectively). Groups
consisted of 4 AHD, 5 CHD, 4 PHD, and 4 SOC gilts.
Values are expressed as means _ SEM.
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Figure 3. Effect of intravenous injection of hpGHRF(1-
40)OH (A and B) or diluent (C) on GH concentrations in
peripheral plasma of prepuberal hypophysial stalk-transected
and unoperated control gilts. Number of gilts in each group
is indicated in parentheses. Values are mean _ SEM.
Figure 4. Effects of L-692,585 on GH secretion is markedly
attenuated in hypothalamic/pituitary transected (HST) pigs.
Activity is restored when GHRH is coadministered with L-
692,429 (6).
Iowa State University     Breeding/Physiology
Table 1. Effect of HST on adrenal, thyroid, and pituitary glands and PRL and GH in gilts.
                         SOC gilts                               HST gilts                    Ratio         
Item n weight n weight HST:SOC
Body (kg)     5 111 _ 4.1a 6 97 _ 5.1 0.874
Adrenal (g)  5 4.9 _ 0.27 6 3.4 _ 0.30b 0.694
Thyroid (g) 5 11.5 _ 1.75 6 11.5 _ 2.51 1.000
Pituitary (mg) 5 342 _ 10 6 213 _ 21b 0.623
Pituitary PRL
  Concentration (_g/mg) 2.1 _ 0.31 0.2 _ 0.05c 0.092
  Content (_g) 711 _ 96 44 _ 14c 0.062
Pituitary GH
  Concentration (_g/mg) 14.2 _ 0.99 9.6 _ 3.72b 0.674
  Content (_g) 4870 _ 390 2175 _ 937b 0.447
aValues are mean _ SEM.
bP < 0.05 vs SOC.
cP < 0.001 vs SOC.
